Tandem Diabetes (TNDM) Releases Favorable Data on t:slim X2

admin March 17, 2023
0 Comments

This article was originally published on Nasdaq

Tandem Diabetes Care, Inc.TNDM recently announced favorable results from the Pediatric Artificial Pancreas (PEDAP) Clinical Trial, published by the New England Journal of Medicine. The participants of the trial comprised children of two-five years of age, with Type 1 Diab

Categories: Nasdaq Stocks

Responses

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to nests
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .